Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer
Clinical trial NCT00083031 · COMPLETED
Trial details
- NCT number
- NCT00083031
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2006-08-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.